《MedRxiv,3月8日,COVID-19 early warning score: a multi-parameter screening tool to identify highly suspected patients》

  • 来源专题:COVID-19科研动态监测
  • 编译者: zhangmin
  • 发布时间:2020-03-09
  • COVID-19 early warning score: a multi-parameter screening tool to identify highly suspected patients

    Cong-Ying Song, Jia Xu, Jian-Qin He, Yuan-Qiang Lu

    doi: https://doi.org/10.1101/2020.03.05.20031906

    Abstract

    BACKGROUND Corona Virus Disease 2019 (COVID-19) is spreading worldwide. Effective screening for patients is important to limit the epidemic. However, some defects make the currently applied diagnosis methods are still not very ideal for early warning of patients. We aimed to develop a diagnostic model that allows for the quick screening of highly suspected patients using easy-to-get variables. METHODS A total of 1,311 patients receiving severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) nucleicacid detection were included, whom with a positive result were classified into COVID-19 group.

    *注,本文为预印本论文手稿,是未经同行评审的初步报告,其观点仅供科研同行交流,并不是结论性内容,请使用者谨慎使用.

  • 原文来源:https://www.medrxiv.org/content/10.1101/2020.03.05.20031906v1
相关报告
  • 《MedRxiv,2月17日,A simple laboratory parameter facilitates early identification of COVID-19 patients》

    • 来源专题:COVID-19科研动态监测
    • 编译者:dingxq
    • 发布时间:2020-02-18
    • A simple laboratory parameter facilitates early identification of COVID-19 patients Qilin Li, Xiuli Ding, Geqing Xia, Zhi Geng, Fenghua Chen, Lin Wang, Zheng Wang doi: https://doi.org/10.1101/2020.02.13.20022830 Abstract The total number of COVID-19 patients since the outbreak of this infection in Wuhan, China has reached 40000 and are still growing. To facilitate triage or identification of the large number of COVID-19 patients from other patients with similar symptoms in designated fever clinics, we set to identify a practical marker that could be conveniently utilized by first-line health-care workers in clinics. To do so, we performed a case-control study by analyzing clinical and laboratory findings between PCR-confirmed SARS-CoV-2 positive patients (n=52) and SARS-CoV-2 negative patients (n=53). The patients in two cohorts all had similar symptoms, mainly fever and respiratory symptoms. The rates of patients with leukocyte counts (normal or decreased number) or lymphopenia (two parameters suggested by current National and WHO COVID-19 guidelines) had no differences between these two cohorts, while the rate of eosinopenia (decreased number of eosinophils) in SARS-CoV-2 positive patients (79%) was much higher than that in SARS-CoV-2 negative patients (36%). When the symptoms were combined with eosinopenia, this combination led to a diagnosis sensitivity and specificity of 79% and 64%, respectively, much higher than 48% and 53% when symptoms were combined with leukocyte counts (normal or decreased number) and/ or lymphopenia. Thus, our analysis reveals that eosinopenia may be a potentially more reliable laboratory predictor for SARS-CoV-2 infection than leukocyte counts and lymphopenia recommended by the current guidelines. *注,本文为预印本论文手稿,是未经同行评审的初步报告,其观点仅供科研同行交流,并不是结论性内容,请使用者谨慎使用.
  • 《3月8日_COVID-19早期预警评分:一种用于识别高度可疑患者的多参数筛选工具》

    • 来源专题:COVID-19科研动态监测
    • 编译者:xuwenwhlib
    • 发布时间:2020-03-10
    • 3月8日_COVID-19早期预警评分:一种用于识别高度可疑患者的多参数筛选工具 1.时间:2020年3月8日 2.机构或团队:浙江大学第一附属医院 3.事件概要: 浙江大学第一附属医院多个科室的科研人员在medRxiv预印本平台发表题为“COVID-19 early warning score: a multi-parameter screening tool to identify highly suspected patients”的文章,旨在开发一种诊断模型,该模型可使用易于获取的变量快速筛查高度可疑的患者。 该研究将SARS-CoV-2核酸检测结果为阳性的1311例患者归为COVID-19组;进行多元逻辑回归分析以构建诊断模型;利用ROC曲线分析来进行模型验证。该研究结果发现,诊断模型包括CT显示的肺炎症状、密切接触史、发烧,中性粒细胞与淋巴细胞比值(NLR)、Tmax和性别。将年龄和有参考性的呼吸道症状纳入COVID-19早期预警评分(COVID-19 early warning score,COVID-19 EWS))。ROC曲线下的面积(AUROC)表明诊断模型(训练数据集0.956 [95%CI 0.935-0.977,P <0.001];验证数据集0.960 [95%CI 0.919-1.0,P<0.001])和COVID-19 EWS(训练数据集0.956 [95%CI 0.934-0.978,P<0.001];验证数据集0.966 [95%CI 0.929-1,P<0.001])均具有良好的判别能力。此外,研究人员还获得了疾病严重程度预测指标的临界值,例如CT评分、CD8+ T细胞计数、CD4+ T细胞计数等。研究结论:新开发的COVID-19 EWS是对SARS-CoV-2感染患者进行早期和相对准确预警的重要工具。 *注,本文为预印本论文手稿,是未经同行评审的初步报告,其观点仅供科研同行交流,并不是结论性内容,请使用者谨慎使用。 4.附件: 原文链接:https://www.medrxiv.org/content/10.1101/2020.03.05.20031906v1